Literature DB >> 27404875

Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.

Mayur Sarangdhar1, Scott Tabar1, Charles Schmidt1, Akash Kushwaha1, Krish Shah1, Jeanine E Dahlquist1, Anil G Jegga1, Bruce J Aronow1,2.   

Abstract

Mesh：

Year:  2016        PMID： 27404875     DOI： 10.1038/nbt.3623

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  28 in total

1.  OpenVigil--free eyeballs on AERS pharmacovigilance data.

Authors:  Ruwen Böhm; Jan Höcker; Ingolf Cascorbi; Thomas Herdegen
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

2.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

3.  Market withdrawal of new molecular entities approved in the United States from 1980 to 2009.

Authors:  Zaina P Qureshi; Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Kurt B Stevenson; Sheryl L Szeinbach
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-05-14       Impact factor: 2.890

4.  Data-driven prediction of drug effects and interactions.

Authors:  Nicholas P Tatonetti; Patrick P Ye; Roxana Daneshjou; Russ B Altman
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

5.  AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.

Authors:  Igor Grigoriev; Wolfgang zu Castell; Philipp Tsvetkov; Alexey V Antonov
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-02-12       Impact factor: 2.890

Review 6.  Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

Authors:  Charles L Bennett; Karen M Starko; Henrik S Thomsen; Shawn Cowper; Oliver Sartor; Iain C Macdougall; Zaina P Qureshi; P Brandon Bookstaver; April D Miller; LeAnn B Norris; Sudha Xirasagar; Alyssa Trenery; Isaac Lopez; Adam Kahn; Alanna Murday; Stefano Luminari; Denis Cournoyer; Francesco Locatelli; Paul Ray; Donald R Mattison
Journal:  J Gen Intern Med       Date:  2012-06-13       Impact factor: 5.128

Review 7.  Data mining of the public version of the FDA Adverse Event Reporting System.

Authors:  Toshiyuki Sakaeda; Akiko Tamon; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

8.  Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study.

Authors:  Agnieszka Butwicka; Louise Frisén; Catarina Almqvist; Björn Zethelius; Paul Lichtenstein
Journal:  Diabetes Care       Date:  2015-02-03       Impact factor: 19.112

9.  Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.

Authors:  Takao Tamura; Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2012-07-25       Impact factor: 3.738

10.  The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.

Authors:  Keith B Hoffman; Mo Dimbil; Colin B Erdman; Nicholas P Tatonetti; Brian M Overstreet
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606
View more
  18 in total

1.  SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System.

Authors:  Gian Paolo Fadini; Benedetta Maria Bonora; Angelo Avogaro
Journal:  Diabetologia       Date:  2017-05-12       Impact factor: 10.122

2.  Thrombocytopenia with Tedizolid and Linezolid.

Authors:  Erica Yookyung Lee; Aisling R Caffrey
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 3.  Multiple sclerosis outcomes after cancer immunotherapy.

Authors:  Catherine R Garcia; Rani Jayswal; Val Adams; Lowell B Anthony; John L Villano
Journal:  Clin Transl Oncol       Date:  2019-02-20       Impact factor: 3.405

4.  Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis.

Authors:  Alex Jiang; Anil G Jegga
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2018-05-18

5.  Clozapine and hematologic adverse reactions: Impact of the Risk Evaluation and Mitigation Strategy program.

Authors:  Eric P Borrelli; Erica Y Lee; Aisling R Caffrey
Journal:  Ment Health Clin       Date:  2020-05-07

6.  Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors.

Authors:  Gian Paolo Fadini; Mayur Sarangdhar; Fabrizio De Ponti; Angelo Avogaro; Emanuel Raschi
Journal:  BMJ Open Diabetes Res Care       Date:  2019-10-04

7.  Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System.

Authors:  Gian Paolo Fadini; Mayur Sarangdhar; Angelo Avogaro
Journal:  BMJ Open Diabetes Res Care       Date:  2018-01-30

8.  Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions.

Authors:  Gian Paolo Fadini; Mayur Sarangdhar; Angelo Avogaro
Journal:  Diabetes Ther       Date:  2018-03-16       Impact factor: 2.945

9.  Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity.

Authors:  Rhodora C Calizo; Smiti Bhattacharya; J G Coen van Hasselt; Chengguo Wei; Jenny S Wong; Robert J Wiener; Xuhua Ge; Nicholas J Wong; Jia-Jye Lee; Christina M Cuttitta; Gomathi Jayaraman; Vivienne H Au; William Janssen; Tong Liu; Hong Li; Fadi Salem; Edgar A Jaimes; Barbara Murphy; Kirk N Campbell; Evren U Azeloglu
Journal:  Nat Commun       Date:  2019-05-03       Impact factor: 14.919

10.  A compound attributes-based predictive model for drug induced liver injury in humans.

Authors:  Yang Liu; Hua Gao; Yudong D He
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.